Company profile
enGene Therapeutics Inc. Insider Trading
ENGNEvery SEC Form 4 insider trading filing for enGene Therapeutics Inc. (ENGN) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001980845
- Filings
- 64
- Insiders
- 28
- Last filing
- 2026-06-16
Activity summary
No insider transactions in the last 30 days. The most recent was on June 16, 2026, when Wouter Joustra bought 31,000 shares. 64 filings from 28 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q2 26. enGene Therapeutics Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $16.0M.
No insider activity recorded for ENGN in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Wouter Joustra | ENGN | Award | 31,000 | — | — |
| Jun 16, 2026 | Lota S. Zoth | ENGN | Award | 31,000 | — | — |
| Jun 16, 2026 | Philip Astley-Sparke | ENGN | Award | 31,000 | — | — |
| Jun 16, 2026 | Gerald A Brunk | ENGN | Award | 31,000 | — | — |
| Jun 16, 2026 | Richard M Glickman | ENGN | Award | 31,000 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ENGN" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of enGene Therapeutics Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →